Healthcare / Medical Care FacilitiesIOB
$51.63
-3.75 (-6.79%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $770.0M · quality 67.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
59/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.5B
P/E
9.5x
↓EV/EBITDA
6.0x
↓ROE
7.6%
↑Gross Margin
95.7%
↑Debt/Equity
1.41
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.9%
FCF CAGR
+6.7%
FCF margin
7.7%
FCF / Net income
3.26x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $10.02B · net income $236.0M · FCF $770.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.02B | $10.02B | $10.30B | $9.64B | $9.20B |
| Net Income | $236.0M | $236.0M | $144.0M | $176.0M | $210.0M |
| EBITDA | $1.11B | $1.11B | $1.06B | $1.02B | $897.0M |
| EPS | 4.73 | 4.73 | 2.87 | 3.72 | 4.37 |
| Gross Margin | 95.7% | 95.7% | 95.4% | 95.1% | 95.3% |
| Operating Margin | 4.6% | 4.6% | 4.9% | 3.9% | 4.5% |
| Net Margin | 2.4% | 2.4% | 1.4% | 1.8% | 2.3% |
| Balance Sheet | |||||
| Debt/Equity | 1.41 | 1.41 | 1.63 | 1.87 | 1.97 |
| Current Ratio | 1.05 | 1.05 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $770.0M | $770.0M | $869.0M | $621.0M | $633.0M |
| Returns | |||||
| ROE | 7.6% | 7.6% | 4.6% | 6.1% | 7.7% |
| Valuation | |||||
| P/E | 9.54 | 9.54 | 12.65 | 7.27 | 9.20 |
| EV/EBITDA | 5.97 | 5.97 | 6.01 | 5.92 | 7.40 |
| P/B | 0.83 | 0.83 | 0.58 | 0.45 | 0.70 |
| Growth & Yield | |||||
| Revenue Growth | -2.7% | -2.7% | 6.8% | 4.8% | — |
| EPS Growth | 64.8% | 64.8% | -22.8% | -14.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-1.1%
EPS terminal req.
$4.58
Spread vs growth
65.9%
5Y implied EPS CAGR
3.2%
EPS terminal req.
$5.54
Spread vs growth
61.6%
10Y implied EPS CAGR
6.6%
EPS terminal req.
$8.93
Spread vs growth
58.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+43.8%
Start / end P/E
12.5x → 10.9x
EPS bridge
2.87 → 4.73
Residual
-8.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.